Results 11 to 20 of about 452 (85)
Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease [PDF]
, 2021 Due to the population aging and the accumulation of concomitant diseases, the prevalence of atrial fibrillation (AF) as the most common arrhythmia is increasing. On the other hand, 14% of the population has chronic kidney disease (CKD).
N. Sh. Zagidullin, P. A. Davtyan
core +2 more sources
, 2020 This review presents data on the frequency of bleeding in direct comparison of apixaban and vitamin K antagonists in the context of prospective randomized controlled trials.
Игорь Явелов
semanticscholar +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Atrial fibrillation (AF) is a risk factor for thromboembolic complications, requiring administration of vitamin K antagonists (warfarin) or the new oral anticoagulants (apixaban, dabigatran and rivaroxaban).Aim. To assess the influence of apixaban use on
A. V. Rudakova
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Background. For prevention of thromboembolic events in patients with non-valvular atrial fibrillation (NVAF) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin K antagonists (such as warfarin), antiplatelet therapy
A. V. Rudakova, V. A. Parfenov
doaj +1 more source
Prognosis and prevention of cardioembolic stroke in patients with atrial fibrillation
Медицинский совет, 2013 The article is a review of literature on the prognosis and prevention of stroke in patients with atrial fibrillation (AF). It is noted that the simple CHA2DS2-VASc calculator is a good predictor of the risk of stroke in AF.
V. А. Parfyonov, S. V. Verbitskaya
doaj +1 more source
POSSIBILITIES OF INHIBITING ANTICOAGULANT ACTIVITIES THAT INHIBIT XA-FACTOR [PDF]
, 2019 The article deals with the possibility of suppressing the effect of drugs inhibiting the activity of the Xa-Factor of the clotting blood system. Wide indications for oral anticoagulants are atrial fibrillation, venous thrombosis, thromboembolism, etc ...
A. D. Erlich
core +4 more sources
Characteristics of atrial fibrillation in older people [PDF]
, 2018 The prevalence of atrial fibrillation (AF) increases with aging. It is associated with serious health consequences. The degenerative changes and the comorbidities result in anatomical substrate for this arrhythmia.
Chalakova, Tatyana, Todorova, Vesela
core +2 more sources
Роль апиксабана в лечении венозных тромбоэмболических осложнений у больных с активным раком [PDF]
, 2020 The relationship of venous thromboembolic complications (VTEC) to cancer is well known. Modern recommendations for the treatment of VTEC in patients with cancer suggest treatment with subcutaneous injections of LMWH in the first 6 months.
E. Panchenko P. +1 more
core +4 more sources
Prevention of cardioembolic stroke
Consilium Medicum, 2020 Кардиоэмболический подтип ишемического инсульта (КЭИИ) – одна из наиболее тяжелых форм цереброваскулярной патологии. Трудности в значи-тельной степени обусловлены объективной сложностью выявления нарушений сердечного ритма – наиболее частой причины КЭИИ,
P. Kamchatnov +2 more
semanticscholar +1 more source
Differences in the activity of coagulation cascade factors and concentrations of fibrinogen and d-dimer, in patients with pulmonary thromboembolism on direct oral anticoagulant therapy [PDF]
, 2023 Терапија директним оралним антикоагулансима (ДОАК) је према савременим водичима препоручена за лечење пацијената са плућном тромбоемболијом (ПТЕ). Није познато на који начин ДОАК-и утичу на активност фактора коагулације који нису њихова директна мета ...
Џудовић, Jелена
core